Lipid-based nanovesicular drug delivery systems
In designing a new drug, considering the preferred route of administration, various
requirements must be fulfilled. Active molecules pharmacokinetics should be reliable with a …
requirements must be fulfilled. Active molecules pharmacokinetics should be reliable with a …
Recent advances and future prospective of topical and transdermal delivery systems
P Tapfumaneyi, M Imran, Y Mohammed… - Frontiers in Drug …, 2022 - frontiersin.org
Recent advances in topical and transdermal drug delivery systems have enabled targeted
delivery of therapeutics to the site of action by enhancing drug permeation across the …
delivery of therapeutics to the site of action by enhancing drug permeation across the …
[HTML][HTML] Novel lipid nanovesicle-loaded dissolving microarray patches for fenretinide in breast cancer chemoprevention
AC Apolinário, YA Naser, F Volpe-Zanutto… - Journal of Controlled …, 2024 - Elsevier
The retinoid fenretinide (FENR) is a promising compound for preventing breast cancer
recurrence but faces challenges due to poor solubility and low bioavailability. This study …
recurrence but faces challenges due to poor solubility and low bioavailability. This study …
A comprehensive review of the biomaterial-based multifunctional nanocarriers for therapeutic applications in breast cancer
Breast cancer is among the most dreadful malignancies in women causing the highest
mortality across the globe. The prevalent therapies have not been able to be efficacious to …
mortality across the globe. The prevalent therapies have not been able to be efficacious to …
Quality-by-design-based engineered liposomal nanomedicines to treat cancer: an in-depth analysis
Engineered nano-sized liposomes have attained the highest success rate in
commercialization among the reported nanomedicines. However, developing industrially …
commercialization among the reported nanomedicines. However, developing industrially …
Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a nanoethosomal-based hydrogel for topical administration of …
Herein, we developed an ethosomal hydrogel based on three types of ethosomes: simple,
mixed (surfactant-based micelles and lipid vesicles) or binary (comprising two type of …
mixed (surfactant-based micelles and lipid vesicles) or binary (comprising two type of …
Exploring contemporary breakthroughs in utilizing vesicular nanocarriers for breast cancer therapy
Breast cancer (BC) is a heterogeneous disease with various morphological features,
clinicopathological conditions and responses to different therapeutic options, which is …
clinicopathological conditions and responses to different therapeutic options, which is …
Aquasomes: a novel platform for drug delivery
M İlhan, HE Gültekin, S Rençber, Z Şenyiğit… - … of Nanovesicular Drug …, 2022 - Elsevier
In recent years, drug research has focused on nanocarrier systems. Self-assembled
nanodrug delivery systems such as liposome, niosome, polymersome, and transfersome …
nanodrug delivery systems such as liposome, niosome, polymersome, and transfersome …
[HTML][HTML] Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase
Seriniquinone (SQ) was initially described by our group as an antimelanoma drug candidate
and now also as an antifungal drug candidate. Despite its promising in vitro effects, SQ …
and now also as an antifungal drug candidate. Despite its promising in vitro effects, SQ …
Optimization of nanoemulsified systems containing lamellar phases for co-delivery of celecoxib and endoxifen to the skin aiming for breast cancer chemoprevention …
G Mojeiko, AC Apolinário, GC Salata, M Chorilli… - Colloids and Surfaces A …, 2022 - Elsevier
We proposed an innovative nanoemulsified system containing lamellar phases (NLP)
produced by a low-energy method to enable the local-transdermal co-delivery of celecoxib …
produced by a low-energy method to enable the local-transdermal co-delivery of celecoxib …